Abstract
A 50-year-old man is described who had a 15-year history of Raynaud’s phenomenon with severe and frequent vasospastic attacks in his fingers and toes during the past years. Exacerbation of his digital symptoms, which started about 4 years ago, was accompanied by signs of thyroid deficiency, such as tiredness, memory impairment, decreased libido, constipation, dryness of skin and bradycardia. Hormonal evaluation revealed primary hypothyroidism and the patient began substitution therapy with L-thyroxine. After 2 months of treatment not only did he become euthyroid but the digital symptoms also disappeared. The patient may thus represent one of the very few cases whose thyroid replacement therapy proved to be highly effective in treating both hypothyroidism and Raynaud’s phenomenon.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Shagan B.P., Friedman S.A. Raynaud’s phenomenon in hypothyroidism. Angiology 27: 19, 1976.
Sipila R., Viitasalo K., Heikkila J. Hypothyroidism, Raynaud’s phenomenon, and acute myocardial infarction in a young woman. Clin. Cardiol. 6: 304, 1983.
Shagan B.P., Friedman S.A. Raynaud’s phenomenon and thyroid deficiency. Arch. Intern. Med. 140: 832, 1980.
Vecsei P. Glucocorticoids: cortisol, corticosterone, cortisone, compound S, and their metabolites. In: Jaffe R.M., Behrman H.R. (Eds.), Methods of Hormone Radioimmunoassay. Academic Press, New York, 1979, p.767.
Gláz E., Kiss R., Lada G., Vida S., Vajda S., Katrics E., Pécsi E. Pathophysiological, clinical and therapeutic aspects of hyperaldosteronism. In: Gláz E. (Ed.), Hyperaldosteronism. Boehringer Mannheim Ltd, Publ. Hungexpo, Budapest, 1979, p.43.
Heidrich H. Etiological aspects of Raynaud’s syndrome. In: Heidrich H. (Ed.), Raynaud’s syndrome. TM-Verlag, Oeynhausen 1975, p.185.
Christensen N.J. Plasma noradrenaline and adrenaline in patients with thyreotoxicosis and myxoedema. Clin. Sci. 45: 163, 1973.
Bilezikan J.P., Loeb J.N. The influence of hyperthyreosis and hypothyroidism on α- and β-adrenergic receptor systems and adrenergic responsiveness. Endocr. Rev. 4: 378, 1983.
Leppert J., Aberg H., Ringquist I. Raynaud’s phenomenon in a female population: prevalence and association with other conditions. Angiology 38: 871, 1987.
Priollet P., Vayssairat M., Housset E. How to classify Raynaud’s phenomenon. Long-term follow up study of 773 cases. Am. J. Med. 83: 494, 1987.
Dessein P.H., Gledhill R.F. Treatment of Raynaud’s phenomenon with large dose of triiodothyronine: a pilot study. Ann. Rheum. Dis. 46: 938, 1987.
Dessein P.H., Gledhill R.F. Tri-iodothyronine in Raynaud’s phenomenon: further objective evidence of its beneficial effect. Br. J. Rheumatol. 27: 244, 1988.
Taylor W. Hand-arm vibration syndrome: a new clinical classification and an updated British standard guide for hand transmitted vibration. Br. J. Ind. Med. 45: 281, 1988.
Scatz I.J. Occlusive arterial disease in the hand due to occupational trauma. N. Engl. J. Med. 260: 281, 1963.
Kallenberg C.G.M., Wouda A.A., The T.H. Systemic autoimmune disease and Raynaud’s phenomenon: a common immunologically mediated, vascular basis? A hypothesis. Neth. J. Med. 27: 322, 1984.
Amino M. Autoimmunity and hypothyroidism. Ballieres. Clin. Endocrinol. Metab. 2: 591, 1988.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lateiwish, A.M., Fehér, J., Baraczka, K. et al. Remission of Raynaud’s phenomenon after L-thyroxine therapy in a patient with hypothyroidism. J Endocrinol Invest 15, 49–51 (1992). https://doi.org/10.1007/BF03348657
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348657